Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

WCLC 2022 | Limitations of the sexual health assessment in woman in LC (SHAWL) study and future directions

Narjust Florez, MD, Dana Farber Cancer Institute, Boston, MA, shares the limitations of the sexual health assessment in woman in lung cancer (SHAWL) study. The SHAWL study included an online questionnaire administered during the COVID-19 pandemic, so many patients could not participate. Additionally, the majority of the population included were White, when sexual health has been associated with cultural differences and healthcare belief differences. Dr Florez hopes to continue studying sexual health in a more diverse population in race and ethnicity, as well as sexual orientation and gender identification and religions and cultures. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.